C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin
- Biochem Biophys Res Commun. 1989 Jul 14;162(1):535-43. doi: 10.1016/0006-291x(89)92030-5.
- 1. Center for Biochemical and Biophysical Sciences and Medicine, Harvard Medical School, Boston, Massachusetts 02115.
Synthetic peptides corresponding to the C-terminal region of angiogenin (Ang) inhibit the enzymatic and biological activities of the molecule while peptides from the N-terminal region do not affect either activity. The peptide Ang(108-121) transiently abolishes the inhibition of cell-free protein synthesis caused by angiogenin coincidentally with its cleavage of reticulocyte RNA. Several C-terminal peptides also inhibit nuclease activity of angiogenin when tRNA is the substrate. Furthermore, peptide Ang(108-123) significantly decreases neovascularization elicited by angiogenin in the chick chorioallantoic membrane assay.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Others
-
target: Angiotensin Receptor
-
target: OthersResearch Areas: Cardiovascular Disease